New Insights into the Pathogenesis of Non-Alcoholic Fatty Liver Disease: Gut-Derived Lipopolysaccharides and Oxidative Stress

Non-alcoholic fatty liver disease (NAFLD) is the most common chronic liver disease worldwide. The intricate NAFLD pathogenesis is summarized by the multiple-hits hypothesis, which combines all the environmental and genetic factors that promote the development of NAFLD into a single scenario. Among t...

Full description

Bibliographic Details
Main Authors: Domenico Ferro, Francesco Baratta, Daniele Pastori, Nicholas Cocomello, Alessandra Colantoni, Francesco Angelico, Maria Del Ben
Format: Article
Language:English
Published: MDPI AG 2020-09-01
Series:Nutrients
Subjects:
Online Access:https://www.mdpi.com/2072-6643/12/9/2762
_version_ 1797554063185805312
author Domenico Ferro
Francesco Baratta
Daniele Pastori
Nicholas Cocomello
Alessandra Colantoni
Francesco Angelico
Maria Del Ben
author_facet Domenico Ferro
Francesco Baratta
Daniele Pastori
Nicholas Cocomello
Alessandra Colantoni
Francesco Angelico
Maria Del Ben
author_sort Domenico Ferro
collection DOAJ
description Non-alcoholic fatty liver disease (NAFLD) is the most common chronic liver disease worldwide. The intricate NAFLD pathogenesis is summarized by the multiple-hits hypothesis, which combines all the environmental and genetic factors that promote the development of NAFLD into a single scenario. Among these, bacterial lipopolysaccharides (LPS) are derived from the overgrowth of Gram-negative bacteria and translocated mainly as a consequence of enhanced intestinal permeability. Furthermore, oxidative stress is increased in NAFLD as a consequence of reactive oxygen species (ROS) overproduction and a shortage of endogenous antioxidant molecules, and it is promoted by the interaction between LPS and the Toll-like receptor 4 system. Interestingly, oxidative stress, which has previously been described as being overexpressed in cardiovascular disease, could represent the link between LPS and the increased cardiovascular risk in NAFLD subjects. To date, the only effective strategy for the treatment of NAFLD and non-alcoholic steatohepatitis (NASH) is the loss of at least 5% body weight in overweight and/or obese subjects. However, the dose-dependent effects of multispecies probiotic supplementation on the serum LPS level and cardiometabolic profile in obese postmenopausal women were demonstrated. In addition, many antibiotics have regulatory effects on intestinal microbiota and were able to reduce serum aspartate aminotransferase (AST), alanine aminotransferase (ALT), and tumor necrosis factor alpha (TNF-α) in NASH animal models. Regarding the oxidant status, a Mediterranean diet has been reported to reduce oxidant stress, while vitamin E at high daily dosages induced the resolution of NASH in 36% of treated patients. Silymarin had the positive effect of reducing transaminase levels in NAFLD patients and long-term treatment may also decrease fibrosis and slow liver disease progression in NASH. Finally, the influence of nutraceuticals on gut microbiota and oxidant stress in NAFLD patients has not yet been well elucidated and there are insufficient data either to support or refuse their use in these subjects.
first_indexed 2024-03-10T16:25:29Z
format Article
id doaj.art-69e3bd3cf5764c4bacd46b817f35884d
institution Directory Open Access Journal
issn 2072-6643
language English
last_indexed 2024-03-10T16:25:29Z
publishDate 2020-09-01
publisher MDPI AG
record_format Article
series Nutrients
spelling doaj.art-69e3bd3cf5764c4bacd46b817f35884d2023-11-20T13:15:05ZengMDPI AGNutrients2072-66432020-09-01129276210.3390/nu12092762New Insights into the Pathogenesis of Non-Alcoholic Fatty Liver Disease: Gut-Derived Lipopolysaccharides and Oxidative StressDomenico Ferro0Francesco Baratta1Daniele Pastori2Nicholas Cocomello3Alessandra Colantoni4Francesco Angelico5Maria Del Ben6I Clinica Medica, Department of Clinical, Internal, Anesthetic and Cardiovascular Sciences, Sapienza University of Rome, 00185 Rome, ItalyI Clinica Medica, Department of Clinical, Internal, Anesthetic and Cardiovascular Sciences, Sapienza University of Rome, 00185 Rome, ItalyI Clinica Medica, Department of Clinical, Internal, Anesthetic and Cardiovascular Sciences, Sapienza University of Rome, 00185 Rome, ItalyI Clinica Medica, Department of Clinical, Internal, Anesthetic and Cardiovascular Sciences, Sapienza University of Rome, 00185 Rome, ItalyI Clinica Medica, Department of Clinical, Internal, Anesthetic and Cardiovascular Sciences, Sapienza University of Rome, 00185 Rome, ItalyDepartment of Public Health and Infectious Diseases, Sapienza University of Rome, 00185 Rome, ItalyI Clinica Medica, Department of Clinical, Internal, Anesthetic and Cardiovascular Sciences, Sapienza University of Rome, 00185 Rome, ItalyNon-alcoholic fatty liver disease (NAFLD) is the most common chronic liver disease worldwide. The intricate NAFLD pathogenesis is summarized by the multiple-hits hypothesis, which combines all the environmental and genetic factors that promote the development of NAFLD into a single scenario. Among these, bacterial lipopolysaccharides (LPS) are derived from the overgrowth of Gram-negative bacteria and translocated mainly as a consequence of enhanced intestinal permeability. Furthermore, oxidative stress is increased in NAFLD as a consequence of reactive oxygen species (ROS) overproduction and a shortage of endogenous antioxidant molecules, and it is promoted by the interaction between LPS and the Toll-like receptor 4 system. Interestingly, oxidative stress, which has previously been described as being overexpressed in cardiovascular disease, could represent the link between LPS and the increased cardiovascular risk in NAFLD subjects. To date, the only effective strategy for the treatment of NAFLD and non-alcoholic steatohepatitis (NASH) is the loss of at least 5% body weight in overweight and/or obese subjects. However, the dose-dependent effects of multispecies probiotic supplementation on the serum LPS level and cardiometabolic profile in obese postmenopausal women were demonstrated. In addition, many antibiotics have regulatory effects on intestinal microbiota and were able to reduce serum aspartate aminotransferase (AST), alanine aminotransferase (ALT), and tumor necrosis factor alpha (TNF-α) in NASH animal models. Regarding the oxidant status, a Mediterranean diet has been reported to reduce oxidant stress, while vitamin E at high daily dosages induced the resolution of NASH in 36% of treated patients. Silymarin had the positive effect of reducing transaminase levels in NAFLD patients and long-term treatment may also decrease fibrosis and slow liver disease progression in NASH. Finally, the influence of nutraceuticals on gut microbiota and oxidant stress in NAFLD patients has not yet been well elucidated and there are insufficient data either to support or refuse their use in these subjects.https://www.mdpi.com/2072-6643/12/9/2762non-alcoholic fatty liver diseaselipopolysaccharideoxidative stresscardiovascular risk
spellingShingle Domenico Ferro
Francesco Baratta
Daniele Pastori
Nicholas Cocomello
Alessandra Colantoni
Francesco Angelico
Maria Del Ben
New Insights into the Pathogenesis of Non-Alcoholic Fatty Liver Disease: Gut-Derived Lipopolysaccharides and Oxidative Stress
Nutrients
non-alcoholic fatty liver disease
lipopolysaccharide
oxidative stress
cardiovascular risk
title New Insights into the Pathogenesis of Non-Alcoholic Fatty Liver Disease: Gut-Derived Lipopolysaccharides and Oxidative Stress
title_full New Insights into the Pathogenesis of Non-Alcoholic Fatty Liver Disease: Gut-Derived Lipopolysaccharides and Oxidative Stress
title_fullStr New Insights into the Pathogenesis of Non-Alcoholic Fatty Liver Disease: Gut-Derived Lipopolysaccharides and Oxidative Stress
title_full_unstemmed New Insights into the Pathogenesis of Non-Alcoholic Fatty Liver Disease: Gut-Derived Lipopolysaccharides and Oxidative Stress
title_short New Insights into the Pathogenesis of Non-Alcoholic Fatty Liver Disease: Gut-Derived Lipopolysaccharides and Oxidative Stress
title_sort new insights into the pathogenesis of non alcoholic fatty liver disease gut derived lipopolysaccharides and oxidative stress
topic non-alcoholic fatty liver disease
lipopolysaccharide
oxidative stress
cardiovascular risk
url https://www.mdpi.com/2072-6643/12/9/2762
work_keys_str_mv AT domenicoferro newinsightsintothepathogenesisofnonalcoholicfattyliverdiseasegutderivedlipopolysaccharidesandoxidativestress
AT francescobaratta newinsightsintothepathogenesisofnonalcoholicfattyliverdiseasegutderivedlipopolysaccharidesandoxidativestress
AT danielepastori newinsightsintothepathogenesisofnonalcoholicfattyliverdiseasegutderivedlipopolysaccharidesandoxidativestress
AT nicholascocomello newinsightsintothepathogenesisofnonalcoholicfattyliverdiseasegutderivedlipopolysaccharidesandoxidativestress
AT alessandracolantoni newinsightsintothepathogenesisofnonalcoholicfattyliverdiseasegutderivedlipopolysaccharidesandoxidativestress
AT francescoangelico newinsightsintothepathogenesisofnonalcoholicfattyliverdiseasegutderivedlipopolysaccharidesandoxidativestress
AT mariadelben newinsightsintothepathogenesisofnonalcoholicfattyliverdiseasegutderivedlipopolysaccharidesandoxidativestress